CLLS
Cellectis S.A.
Company Overview
| Mkt Cap | $258.10M | Price | $3.45 |
| Volume | 14.43K | Change | -0.86% |
| P/E Ratio | -7.0 | Open | $3.46 |
| Revenue | $41.5M | Prev Close | $3.48 |
| Net Income | $-36.8M | 52W Range | $1.10 - $5.48 |
| Div Yield | N/A | Target | $6.80 |
| Overall | 47 | Value | -- |
| Quality | 44 | Technical | 50 |
No chart data available
Stock Overview
Updated DailyCellectis S.A. (CLLS) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.45 with a market capitalization of $258.10 million. The stock is trading in the middle of its 52-week range, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows CLLS with a volume of 14K shares. The stock opened down 0.57% from yesterday's close of $3.48. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
CLLS demonstrates neutral technical outlook based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including QURE, NVAX, CALA, REGN.
Key investment considerations for CLLS include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 97.1%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 10:55 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLLS | $3.45 | -0.9% | 14.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |